Therefore, we speculated that it is highly likely that the overexpression of HAS3 promotes the abnormal biosynthesis of HA, and then excess accumulated HMW-HA can be further degraded into LMW-HA by HYAL2, which ultimately accelerates the malignant progression of glioma. Here, HAS3 is linked to central nervous system cancer.